Synovial fluid and peripheral blood mononuclear cell proliferative responses to the 60-kD human heat shock protein (HSP60) were studied in 23 patients with juvenile chronic arthritis (JCA) and 7 non-JCA control patients. All patients showed active arthritis at the time of study. The patients were divided into two groups according to the presence (group A) or absence (group B) of T lymphocyte reactivity to human HSP60. We show that reactivity to human HSP60 is primarily, though not exclusively, occurring in patients with a remitting course of disease, i.e., the subgroup of HLA-B27 negative JCA patients with an oligoarticular onset. Immunohistochemical analysis of HSP expression in synovial membranes showed a significantly higher intensity of staining in JCA patients than in non-JCA controls. The results suggest that, in accordance with the earlier observation made in experimental models, T lymphocyte reactivity to human HSP60 in this subgroup of JCA patients may be part of T cell regulatory mechanisms that control the development of arthritis. (J. Clin. Invest. 1995. 95:934-940.)
Introduction
Juvenile chronic arthritis (JCA)' encompasses a heterogeneous group of rheumatic diseases. Three subgroups of JCA (oligoarticular, polyarticular, and systemic onset) are recognized. They can be distinguished on the basis of clinical features presenting during the first 3 mo of the disease (1) . The etiology of JCA is still unknown and the pathogenetic mechanisms remain unclear.
Recent research in the field of rheumatology has focused on the key position of T lymphocytes in the immunopathologic 1 . Abbreviations used in this paper: AA, adjuvant arthritis; ANA, antinuclear antibodies; HSP60, heat shock protein; JCA, juvenile chronic arthritis; MNC, mononuclear cells; MT, Mycobacterium tuberculosis. mechanisms leading to disease. Experimental models of arthritis, such as adjuvant arthritis (AA), have been instrumental in this respect (2). The mycobacterial 65-kD antigen (member of the HSP60 heat shock protein family) was defined originally as a crucial antigen associated with disease development (3) . This has initiated an analysis of the role of bacterial HSP60 or its endogenous mammalian homologue HSP60 in various forms of arthritis, both in animals and in humans. In the experimental model of arthritis in animals it has become clear that immunity to mycobacterial HSP60 develops irrespective of how the arthritis was induced. This was seen not only in AA in rats but also in pristane-induced arthritis in mice (4) and streptococcal cell wall induced arthritis in rats (5). Subsequently, it has been shown in these models and in collagen-induced arthritis (6) that preimmunization with HSP60 itself or transfer of HSP60-primed T lymphocytes induced resistance to arthritis. These experimental data have been interpreted as indicating that T lymphocyte reactivity against mycobacterial HSP60 is part of regulatory mechanisms that control the development of arthritis (2).
Recently, we showed that the 60-kD human heat shock protein (human HSP60) can be a target antigen for synovial fluid and peripheral blood mononuclear cells (PBMC) in JCA patients (7) . This finding prompted us to evaluate in more detail the significance of in vitro reactivity to human HSP60 of mononuclear cells (MNC) from patients with JCA. To this end, a number of JCA patients with active arthritis were grouped according to the presence or absence of anti-human HSP60 reactivity, either of synovial fluid MNC or of PBMC. Apart from clinical analysis, T lymphocyte subsets in peripheral blood and synovial fluid were determined, next to expression of HSP60 in synovial membranes by immunohistochemistry (8) . We (Table I, patients 10-14 and 19-23) , only the proliferative response of synovial fluid-or peripheral blood-derived T lymphocytes to human HSP60 could be assessed. 15 of the 23 patients had an oligoarticular onset of JCA, 6 patients had a polyarticular onset, and 2 patients and osteoid osteoma, respectively, which were reasons to reject the diagnosis of JCA. The mean duration of their symptoms was 1.1 yr. Rheumatoid factor was negative in six non-JCA patients. Three non-JCA patients were ANA positive. One out of six non-JCA patients was HLA-B27 positive. Synovial biopsy samples were available for all seven non-JCA patients taken during arthroscopy of the knee (n = 6) or the hip (n = 1). The synovial fluid of the non-JCA patients did not contain sufficient MNC to perform phenotyping and/or lymphocyte stimulation studies. Peripheral blood samples were taken at the time of the biopsy.
Peripheral blood also was collected from nine healthy children (age range 8.0-15.4 yr).
Peripheral blood and synovialfluid assays. MNC were isolated from heparinized blood or synovial fluid by Ficoll-Isopaque density gradient centrifugation (Pharmacia AB, Uppsala, Sweden). The cells were suspended at a density of 0.5 x 106/ml in RPMI 1640 tissue culture medium, supplemented with 20% heat-inactivated (30 min, 56°C) human AB serum, 100 1g/ml penicillin, 100 U/ml streptomycin, and 200 Mg/ml (11) ; HPLC-purified human HSP60 fractions (10 tig/ml) and HPLC control fractions for human HSP60 (10 ,ug/ml) as described previously (7); tetanus toxoid (3.5 limit flocculation units/ml); and diphtheria toxoid (3.5 tg/ml). Pokeweed mitogen (10 ,ug/ml; Calbiochem-Novabiochem
Corp., La Jolla, CA) was used as polyclonal activator.
The purity of the human HSP60 preparation was determined by ELISA using a panel of mAbs that react with GroEL, the E. coli HSP60. Optical density (OD) values of wells coated with 1 jug/ml human HSP60 Histology and immunohistochemistry. For histology, part of the synovium biopsy samples was fixed in buffered formalin and embedded in paraffin. 6-itm sections were stained with hematoxylin and eosin. All sections of the JCA patients and the non-JCA control patients were reviewed histologically for the degree of synovitis (scored as absent, mild, moderate, and severe). For immunohistochemistry (see below)
another part was snap-frozen and stored at -70°C until analysis. For detection of HSP, five murine monoclonal antibodies were used: F8, raised against a synthetic peptide encompassing amino acid residues 180-188 of mycobacterial HSP60 (8) ; ML-30, raised against the mycobacterial HSP60 of M. leprae (8) ; N-27, a monoclonal antibody which recognizes both the inducible and constitutive forms of human HSP70 (7) ; LKI, a murine monoclonal raised against human HSP60, which binds only to mammalian HSP60 (12) ; and LK2, a murine monoclonal raised against human HSP60, which binds to human HSP60 and bacterial HSP60 as well (12 
Results
Patients and definition of groups. T lymphocyte proliferative responses to human HSP60 were tested for synovial fluid or peripheral blood from 23 children suffering from JCA (Fig. 1) . To evaluate the significance of this response to human HSP60, the JCA patients were divided into two groups (A and B). A positive response of either synovial fluid or peripheral blood T lymphocytes (i.e., stimulation index above 3) was observed in 14 patients (Table I , group A, patients [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Nine patients showed a stimulation index below 3 (Table I , group B, patients [15] [16] [17] [18] [19] [20] [21] [22] [23] . In addition, the proliferative response to human HSP60 was assessed in seven non-JCA control patients as well as in nine healthy children (Fig. 1) . One non-JCA patient (a HLA-B27-positive boy with a transient arthralgia) and one healthy child also had a positive response. The other non-JCA controls and healthy children showed a negative response. To exclude that the observed in vitro proliferative anti-HSP60 T cell re-936 de Graeff-Meeder et al.
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-U- The significance of T lymphocyte reactivity to human HSP60 was evaluated by multiparameter analysis of the 13 patients, for which data were available on membrane phenotyping of MNC in synovial fluid and/or peripheral blood; proliferative responses of synovial fluid and peripheral blood T lymphocytes to HSP60 and other antigens; histology and immunohistochemistry of synovial membranes; and data on the clinical course of the disease. Of these 13 JCA-patients available for multiparameter analysis, 9 (patients 1-9 in Table I Table II . The percentage of CD8+, CD4+DR+, and CD8+DR+ MNC in the synovial fluid of the JCA patients was significantly higher than in the peripheral blood of these patients and the non-JCA controls. Two-color staining for CD4 and CD29 showed that the fraction of CD29+ cells within the CD4+ population, which represent memory T cells (13) , is significantly higher in synovial fluid (70.1%) than in peripheral blood of patients (16.7%) and controls (19.9%) . This is in accordance with reports on adult RA patients (14) . No differences in synovial fluid and peripheral blood lymphocyte subsets were observed between patients of group A and group B. However, the fraction of CD4+CD29+ (Table III) . For PBMC these responses were not significantly different between groups A, B, and the non-JCA controls (data not shown). For synovial fluid MNC a significant correlation was observed between the anti-human HSP60 responses and the response to MT (r = 0.900; P = 0.002) and to mycobacterial HSP60 (r = 0.842; P = 0.004). When the correlation was analyzed for synovial fluid MNC of patients of group A, we found only a significant correlation between the response to human HSP60 and mycobacterial HSP60 (r = 0.821; P = 0.028). For PBMC a correlation was found between the response to human HSP60 and to MT (r = 0.726; P = 0.009). The in vitro response of synovial fluid MNC to the antigens tetanus toxoid and diphtheria toxoid was higher in patients of group A than in those of group B (data not shown). However, the difference was not statistically significant. Moreover, no correlation existed with lymphocyte reactivity to any of the HSP-related antigens.
Immunohistochemistry. Data on expression of HSP60 or related molecules in synovial membranes are presented in Table  IV and Fig. 2 . In the group of JCA patients (groups A and B together) and non-JCA controls, a cytoplasmic staining pattern was observed for the antibodies F-8, N-27, LK-1, and LK-2. The staining patterns of the various antibodies to HSP were not essentially different, but differences were observed in the intensity of labeling. On macrophages a higher expression of HLA-DR was found in JCA patients as compared with non-JCA controls (Fig. 2) . When staining of the synovial lining layer, connective tissue, macrophages, and endothelium of blood vessels were scored together, significant differences in intensity were noted between samples of groups A, B, and the non-JCA controls (Table IV) . Lowest intensity was found in the group of non-JCA control specimens. In addition, the score of staining of the synovial lining layer, connective tissue, macro- phages, and endothelium of blood vessels was analyzed separately for the different antibodies (Fig. 2) . A significant higher intensity of staining of the lining layer was found for F-8 (groups A and B versus controls, respectively; both P < 0.05), ML-30 (group A versus controls; P < 0.001), and for LK-2 (group A versus B and group A versus controls, respectively; both P < 0.05). The intensity of staining by F-8 of the endothelium of the blood vessels was also significant higher ( and B versus controls, respectively; both P < 0.05). For the connective tissue, a significant higher intensity of staining was found for ML-30 (group A and B versus controls, respectively; both P < 0.05), N-27 (group A versus controls; P < 0.05), and LK-1 (group A versus controls; P < 0.05). Macrophages showed significant differences for F-8 (group A and B versus controls, respectively; P < 0.001 and 0.05, respectively), ML-30 (group A and B versus controls, respectively; both P < 0.05), and HLA-DR (group A and B versus controls, respectively; both P < 0.05; Fig. 2 and data not shown). Analysis ofclinical characteristics of the disease. The duration of the disease and of the current arthritis and the severity of the arthritis and functional class score were compared between all patients from groups A and B and the control group (Fig. 3) . The duration of the disease was not significantly different between JCA patients of groups A and B and the non-JCA controls. The duration of the arthritis was significantly shorter for group A than the non-JCA controls (P < 0.05). The score of arthritis activity was significantly higher in group A (mean score 1.8; range 1-2) and group B (mean score 2 for all patients) than in the non-JCA controls (score 1 for all non-JCA controls; both P < 0.05). The score of the functional class of the patients of group A (mean score 1.4; range 1-2) differed significantly from group B (mean score 1.8; range 1-2; P < 0.05). The score of the functional class of group B was significantly different from the non-JCA controls (median score 1; range 1-2; P < 0.05).
Discussion
Heat shock proteins have received ample attention as possible target antigens of the immune response in both infectious and autoimmune diseases (15) (16) (17) (18) (19) . The proteins are highly evolu-tionarily conserved and they behave as dominant immunogens. In the experimental model of AA, mycobacterial HSP60 has been identified as the key antigen. The crucial epitope was located at amino acid positions 180 to 188 (3). The amino acid sequence of this epitope shows sequence homology with rat proteoglycan link protein, which supports earlier suggestions that rat proteoglycan is a target antigen in AA (20). However, the alternative possibility of endogenous HSP as a potential target antigen in arthritis in rats remains to be substantiated. Recently, we could document T lymphocyte reactivity to human HSP60 in patients with JCA (7) and the same phenomenon was found in reactive arthritis (21) . Since bacterial and human HSP60 show a 60% sequence identity at the amino acid level (22) , this has led to the hypothesis that a response originally triggered by bacterial HSP might induce T lymphocytes which recognize epitopes shared by bacterial and self HSP (15, 23) . Alternatively, it is possible that the antibacterial HSP reactivity is secondary to the reactivity against endogenous HSPs, overexpressed in the joint during inflammation.
Recently it was shown that T cell clones from synovial fluid of HLA-B27+ JCA patients that were raised against mycobacterial HSP65 also could be induced to proliferate to GroEL or human HSP60 (24) , and it was suggested that the response to both mycobacterial HSP65 and human HSP60 could be caused by contaminating GroEL in those preparations. In our studies, we have used HPLC-purified recombinant human HSP60. Although during the production procedure recombinant human HSP60 is insoluble while GroEL is a soluble protein, and although there was no reactivity with GroEL recognizing mAbs, we cannot rule out that the recombinant product is contaminated with trace amounts of GroEL, the E. coli equivalent of human HSP60. In vitro culture of JCA T cells with GroEL in doses up to 10 Mg/ml, however, induced only modest responses in 3 out of 11 patients studied for that purpose. Furthermore, it should be noted that in vitro culture with the control preparation (HPLC-purified material from mock-transfected bacteria [7] ) in no case induced T cell proliferation above the medium control. This indicates that the T cell proliferation to human HSP60 as observed in primary cultures of peripheral blood lymphocytes of HLA-B27-JCA patients cannot be attributed to contaminating GroEL.
To investigate the significance of a positive T lymphocyte proliferative response to human HSP60, we made a comparison between JCA patients with a positive response (group A) and patients with a negative response (group B) with regard to lymphocyte subset distribution, expression of HSP in synovial membranes, and clinical characteristics. As far as the lymphocyte phenotyping is concerned, we observed a significant increase in CD4+DR+ and CD8+DR+ T lymphocytes in the synovial fluid of both group A and B. This underscores the role of T lymphocytes in the inflammatory process in the joint. A number of previous studies have characterized lymphocyte subsets in the synovial fluid and peripheral blood of patients with JCA by analyzing MNC for cell surface markers and several activation markers (for review see reference 25). Generally, synovial fluid lymphocytes showed a decrease in CD4' T cells, an increase in CD8+ T cells, and an increase in T cells with varying activation markers. Data in JCA patients are similar to those of patients with the adult form of RA (14, 26) . We documented an increase of CD4+CD29+ memory T cells (13) in the synovial fluid and peripheral blood of patients with JCA (Table II) . The highest percentage was found in group B, i.e., in those patients with a tendency for longer duration of disease and symptom;s (Fig. 3) . These results suggest an ongoing lymphocyte-mediated process in patients of group B. Since these patients are by definition nonreactive to human HSP60, the results of T cell phenotyping may suggest more profound defective immunoregulation than in patients of group A. However, whether the results of phenotyping are directly related to human HSP60 reactivity remains to be clarified. In adult RA patients it is shown that the percentage of CD4+CD29+ is higher in synovial fluid than in peripheral blood (14) . The finding of the highest number of CD4+CD29+ cells in group B is interesting since these patients most resemble the seronegative adult RA patients in mainy aspects.
The pattern of expression in the synovial membranes of human HSP60 as detected by the monoclonal antibody LK-I paralleled expression of HSP-related molecules as demonstrated by the crossreactive antibodies LK-2, F-8, and ML-30 (7, 8) . The results showed that the JCA patients of both groups showed a higher intensity of labeling of the antibodies than the controls (Table IV) . The pattern of staining and the localization (Fig. 2) were similar to our earlier findings in RA patients (8) , where only crossreactive antibodies were used. In one patient (Table  I, Taken together our results show that in vitro T cell response to human HSP60 predominantly, though not exclusively, occurs in JCA patients of the HLA-B27-negative oligoarticular subgroup with an active arthritis. Since patients from this subgroup of JCA usually show a short term of disease and favorable outcome it is tempting to hypothesize that T cell reactivity to human HSP60 in these patients is associated with immunoregulatory control rather than with progression of disease. Our results also show that T cell reactivity to human HSP60 is not Aniti-Hiu,anIHSP60 T Cell Response in Juvenile Chronzic Artlhritis 939 strictly confined to the subgroup of patients with an oligoarticular onset but may occur in polyarticular JCA patients as well (this study and our unpublished results). The selection of HSP epitopes for T lymphocyte activation, that may determine progression and outcome of the disease, may be different for patients with either the oligoarticular onset type or the polyarticular type of disease. The finding that the various JCA subtypes show different HLA associations supports this concept (27). In our group of patients, the frequency of HLA susceptibility alleles (e.g., 41% HLA-DPBI*0201) corresponded with known HLA associations in JCA (28) . There was, however, no relation between any particular HLA haplotype or allele and the in vitro anti-human HSP60 T cell response (data not shown). As 
